Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript
Summarize this article with:
SA Transcripts157.32K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Roche Holding AG (RHHBY) Shareholder/Analyst Call December 11, 2025 10:30 AM EST Company Participants Bruno Eschli - Head of Investor RelationsMaura DicklerPablo Perez-MorenoBenjamin Lilienfeld - Senior Vice PresidentTeresa Graham - Chief Executive Officer of Roche PharmaceuticalsCharles Fuchs - Global Head of Oncology & Hematology Drug Development - Genentech & RocheAzad Bonni - Global Head of pRED Neuroscience & Rare DiseasesHideki Garren Conference Call Participants Aditya BardiaEmmanuel Papadakis - Deutsche Bank AG, Research DivisionColin White - UBS Investment Bank, Research DivisionPeter Verdult - BNP Paribas, Research DivisionRichard Vosser - JPMorgan Chase & Co, Research DivisionLuisa Hector - Joh. Berenberg, Gossler & Co. KG, Research DivisionJames Quigley - Goldman Sachs Group, Inc., Research DivisionSachin Jain - BofA Securities, Research DivisionSimon Baker - Rothschild & Co Redburn, Research DivisionSteve Scala - TD Cowen, Research Division Presentation Operator Good morning. Welcome to Roche Virtual Oncology SABCS Investor Event. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. [Operator Instructions] roche.com/invstors to download the presentation. At this time, it's my pleasure to introduce you to Bruno Eschli, Head of Investor Relations. Bruno, the stage is yours. Thanks, Henrik. And could I have the first slide, please? Bruno EschliHead of Investor Relations So welcome to our eighth and last IR event for 2025, focusing on the Phase III lidERA results for giredestrant in early ER-positive breast cancer, which just got presented yesterday at the San Antonio Breast Cancer Symposium. As an upfront remark, let me just point out also the event originally had been scheduled for 60 minutes. We have now planned for 90 minutes just to make sure that we have enough time that we can take all your questions, which I'm sure there will be plenty of them. So let Recommended For You